Bicara Therapeutics Inc. Common Stock (BCAX) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Bicara Therapeutics Inc. Common Stock (BCAX) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

BCAX Income Statement

Bicara Therapeutics Inc. Common Stock (BCAX) annual income statement — 4-year revenue, gross profit & net income history

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q1'23

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	59.95M	60.24M	41.12M	40.68M	32.02M	41.79M	26.64M	20.63M	19.75M	15.37M	13.69M	8.34M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	14.18M	12.74M	8.13M	7.7M	7.22M	7.46M	6.75M	4.76M	3.91M	3.34M	3.13M	1.78M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	45.77M	47.5M	32.99M	5.82M	24.8M	34.33M	19.88M	15.86M	15.84M	12.03M	10.56M	6.56M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	1000K	0	0	0	0	0	0	0	0
Operating Income	-59.95M	-60.24M	-41.12M	-40.68M	-32.02M	-41.79M	-26.64M	-20.63M	-19.75M	-15.37M	-13.69M	-8.34M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-87.24%	-44.16%	-54.38%	-97.19%	-62.12%	-171.81%	-94.62%	-	-	-84.43%	-	-
EBITDA	-59.91M	-60.2M	-41.08M	-40.65M	-32M	-41.77M	-26.62M	-20.61M	-19.74M	-15.36M	-13.67M	-8.33M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-87.22%	-44.12%	-54.3%	-97.22%	-62.13%	-171.92%	-94.7%	-	-	-84.31%	-	-
D&A (Non-Cash Add-back)	44K	44K	43K	24K	19K	19K	15K	15K	13K	13K	14K	1.5K
EBIT	-55.38M	-56.16M	-37.33M	-36.29M	-27.34M	-36.77M	-20.77M	-17.48M	-17.05M	-12.51M	-25.78M	-8.34M
Net Interest Income	4.58M	4.08M	3.79M	4.39M	4.68M	5.01M	5.87M	3.15M	2.7M	2.87M	1.3M	0
Interest Income	4.58M	4.08M	3.79M	4.39M	4.68M	5.01M	5.87M	3.15M	2.7M	2.87M	1.3M	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	4.58M	4.08M	3.79M	4.39M	4.68M	5.01M	5.87M	3.15M	2.7M	2.87M	1.25M	-14K
Pretax Income	-55.38M	-56.16M	-37.33M	-36.29M	-27.34M	-36.77M	-20.77M	-17.48M	-17.05M	-12.51M	-12.44M	-8.35M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	61K	-52K	53K	40K	52K	72K	186K	0	0	1K	5K	0
Effective Tax Rate %	-0.11%	0.09%	-0.14%	-0.11%	-0.19%	-0.2%	-0.9%	0%	0%	-0.01%	-0.04%	0%
Net Income	-55.44M	-56.21M	-37.39M	-36.33M	-27.39M	-36.85M	-20.96M	-17.48M	-17.05M	-12.51M	-12.44M	-8.35M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-102.41%	-52.56%	-78.39%	-107.83%	-60.64%	-194.58%	-68.46%	-	-	-49.8%	-	-
Net Income (Continuing)	-55.44M	-56.11M	-37.39M	-36.33M	-27.39M	-36.85M	-20.96M	-17.48M	-17.05M	-12.51M	-12.44M	-8.35M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.82	-0.93	-0.68	-0.67	-0.50	-0.68	-0.38	-0.32	-0.27	-0.27	-0.23	-0.15
EPS Growth %	-64%	-36.76%	-78.95%	-109.38%	-85.19%	-151.85%	-65.22%	-	-	-80%	-	-
EPS (Basic)	-0.82	-0.93	-0.68	-0.67	-0.50	-0.68	-0.38	-0.32	-0.27	-0.27	-0.23	-0.15
Diluted Shares Outstanding	67.93M	60.72M	55.14M	54.56M	54.54M	54.46M	54.44M	54.41M	54.18M	54.18M	53.09M	54.62M
Basic Shares Outstanding	67.93M	60.72M	55.14M	54.56M	54.54M	54.46M	54.44M	54.41M	54.18M	54.18M	53.09M	54.6M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-